AUROBINDO PHARMA LTD. - 524804 - Unit III Of Eugia Pharma Specialities Ltd., Receives Warning Letter From US FDA

Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Value Stock, Under Radar

1147.8000 -25.10 (-2.14%)

NSE May 30, 2025 15:31 PM

27.90% Fall from 52W High

Volume: 2.0M

Aurobindo Pharma Ltd.

16 Aug 2024

1147.80

-2.14%

Company Update

AUROBINDO PHARMA LTD. - 524804 - Unit III Of Eugia Pharma Specialities Ltd., Receives Warning Letter …

BSE India

Intimation of receipt of Warning Letter from US FDA for Unit III of Eugia Pharma Specialities Limited, a wholly owned subsidiarity of the Company

More from Aurobindo Pharma Ltd.

Recommended

Five Interesting Stocks Today - May 30, 2025

The Baseline | 30 May 2025, 05:44PM

Market closes lower, Lemon Tree Hotels' Q4 net profit beats Forecaster estimates by 13.5%

Trendlyne Marketwatch | 30 May 2025, 03:54PM

A deal is called off, increasing the chance for Aurobindo Pharma to be debt free